Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

All

News

Sport

Culture

Lifestyle

The one surprising impact of weight loss jab Ozempic

A new Danish study indicates that semaglutide, marketed as Wegovy and Ozempic , may help individuals grappling with alcohol use disorder.

The 26-week trial involved 108 obese patients with alcohol use disorder, with half receiving semaglutide and the other half a placebo, alongside talking therapy.

Participants administered semaglutide showed a significant reduction in heavy drinking days, decreasing from an average of 17 to five per month, and a substantial drop in overall alcohol consumption.

Researchers suggest that semaglutide influences the biological mechanisms underlying addiction, potentially offering a new complementary treatment approach for alcohol use disorder.

Experts acknowledge the encouraging early findings but emphasise the necessity for larger, longer-term trials across diverse…